MITOCHONDRIAL DNA SCREENING PANEL (POINT MUTATIONS AND DELETIONS)

MITOCHONDRIAL DNA ANALYSIS


Mitochondrial DNA disorders are a group of maternally inherited clinically and genetically heterogeneous multisystemic disorders. The mitochondrial DNA mutation screen includes the analysis for the point mutations or large DNA deletions in the mitochondrial genome that cause the mitochondrial syndromes listed below.

Disorders

Mutations

Gene

MELAS (mitochondrial encephalopathy, lactic acidosis, stroke-like episodes)

3243A>G, 3271T>C

tRNALeu(UUR)

MERRF (myoclonic epilepsy and ragged red fibers)

8344A>G, 8356T>C

tRNAlys

NARP (neuropathy, ataxia, retinitis pigmentosa), Leigh syndrome

8993T>G, 8993T>C

ATPase-6

Cardiomyopathy

8363G>A

tRNAlys

Leigh, Leigh-like disease, MELAS 13513G>A, 13514A>G  ND5

LHON (Leber’s Optic Neuropathy)

11778G>A, 3460G>A, 14459G>A, 14484T>C

ND4, ND1, ND6

Kearns-Sayre syndrome

large deletions

tRNAs+mRNA

CPEO (chronic progressive external ophthalmoplegia)

large deletions

tRNAs+mRNA

Pearson marrow/pancreas syndrome

large deletions

tRNAs+mRNA

Maternally inherited diabetes/hearing loss

large deletions

tRNAs+mRNA

Mitochondrial DNA Deletion Syndrome

 

 


Reasons for Referral:

  • Multisystemic disorders involving neuromuscular, neurosensory, central nervous system, cardiac, renal, hepatic, GI, immune, and endocrine systems
  • Family history of mitochondrial disorders
  • Matrilineal family members with known mitochondrial DNA mutations
  • Confirmation of mitochondrial disease

Testing Methodology:

Point mutations are detected by a multiplex PCR/ASO method and quantified by real time ARMS quantitative PCR. Large deletions are detected by Southern analysis.

Sensitivity:

Heteroplasmic point mutations at as low as 1% can be detected. Single deletions of larger than 500 bp at greater than 10% heteroplasmy can be detected by Southern analysis.

Specimen Requirements:

Blood: EDTA (purple-top) tubes: Adult: 14 cc; Child: 6 cc; Infant: 2-3 cc. Patients with suspected Kearns-Sayre syndrome should submit muscle specimen for analysis.
Tissue: Skeletal muscle (Preferred). 50 mg for muscle DNA analysis, 150mg for muscle ETC analysis, >200mg if additional tests are requested. Heart, brain, liver, kidney or fibroblast cultures also accepted. 50 mg of heart, brain, liver, kidney or fibroblast for DNA analysis. Tissues such as liver and kidney should be snap-frozen at collection, stored at -70, and shipped on 3-5 lbs of dry ice.

Turnaround Time:

3 weeks

CPT Codes and Prices:

83896x20, 83894x2, 83893x18, 83892x2, 83912, 83901, 83897x2, 83891, 83900

Shipping Information


Forms:

>> Mitochondrial Requisition - Mitochondrial Diagnostic Checklist is included

Recommended Clinical Testing Algorithm for Mitochondrial Disorders

References:

  1. Wong LJC, Boles R. (2005) Mitochondrial DNA in clinical laboratory diagnostics. Review Article, Clinica Chimica Acta 354: 1-20.
  2. Shanske S, Wong LJC. (2004) Molecular analysis for mitochondrial DNA disorders. Mitochondrion 4: 403-415.
  3. Liang MH, Wong LJC. (1998) Yield of mtDNA mutation analysis in 2000 patients. Am. J. Med. Genet. 77: 395-400.

Test Codes:

3000